PMDA — authorised 23 January 2020
- Marketing authorisation holder: Eisai Co., Ltd.
- Status: approved
🇯🇵 Fycompa in Japan
PMDA authorised Fycompa on 23 January 2020
Marketing authorisation
Fycompa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Japan
Frequently asked questions
Is Fycompa approved in Japan?
Yes. PMDA authorised it on 23 January 2020.
Who is the marketing authorisation holder for Fycompa in Japan?
Eisai Co., Ltd. holds the Japanese marketing authorisation.